Skip to main content

Table 3 Baseline features of the studies which were included

From: Stent thrombosis associated with drug eluting stents on addition of cilostazol to the standard dual antiplatelet therapy following percutaneous coronary intervention: a systematic review and meta-analysis of published randomized controlled trials

Studies Age (years) Males (%) HT (%) Ds (%) DM (%) Cs (%)
  DT/TT DT/TT DT/TT DT/TT DT/TT DT/TT
Ahn2008 [10] 62.0/61.2 54.7/61.7 54.0/48.9 25.2/19.1 100/100 34.5/39.5
Gao2013 [11] 55.3/57.6 81.9/78.9 54.4/56.3 21.4/24.9 16.2/19.2 42.3/38.5
Han2009 [12] 60.2/59.6 72.9/73.8 56.1/57.9 45.4/45.5 20.1/23.3
Lee2005 [13] 59.0/59.0 71.8/71.8 46.1/42.3 27.6/26.8 26.2/23.4 31.9/32.4
Lee2010A [14] 61.0/60.9 60.7/62.2 57.1/57.0 28.5/30.2 62.4/63.3 34.7/31.6
Lee2011 [15] 62.1/60.9 71.5/70.0 64.7/58.4 45.0/42.4 33.7/36.8 30.1/30.4
Suh2011 [16] 64.0/64.8 68.3/68.6 66.6/64.5 32.2/35.5 26.8/23.7
Youn2014 [17] 64.2/65.0 64.2/63.0 65.8/68.2 47.6/49.4 30.9/32.5 44.0/48.4
Zhu2015 [18] 60.1/60.2 64.9/66.9 45.7/41.6 57.0/51.3 21.9/17.5 32.5/39.0
Park2013 [19] 63.7/62.8 67.0/69.8 68.6/66.8 62.7/64.2 31.3/31.8 30.8/32.8
  1. Abbreviations: DT: Dual antiplatelet therapy, TT: Triple antiplatelet therapy, HT: Hypertension, ds: Dyslipidemia, DM: Diabetes mellitus, Cs: Current smoker